These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20158609)

  • 21. Portal hypertension and blood viscosity.
    Sikuler E
    J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics.
    Cahill PA; Hou MC; Hendrickson R; Wang YN; Zhang S; Redmond EM; Sitzman JV
    Hepatology; 1998 Aug; 28(2):396-403. PubMed ID: 9696003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physiopathology of ascites in portal hypertension.
    Michielsen PP
    Acta Gastroenterol Belg; 1996; 59(3):191-7. PubMed ID: 9015930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
    Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
    J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of tissue-type plasminogen activator (t-PA) in the splanchnic circulation of the anaesthetised pig during high sympathetic tone.
    Björkman JA; Ilebekk A; Jern C
    Thromb Res; 2010 Mar; 125(3):e106-9. PubMed ID: 19931890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological control of portal hypertension.
    Polio J; Groszmann RJ
    Prog Liver Dis; 1993; 11():231-49. PubMed ID: 8272513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of extrahepatic vasodilation in portal hypertension.
    Hennenberg M; Trebicka J; Sauerbruch T; Heller J
    Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the development of portosystemic shunts in the maintenance of portal hypertension in rats].
    Braillon A; Koshy A; Lee SS; Girod C; Lebrec D
    Gastroenterol Clin Biol; 1988; 12(8-9):641-5. PubMed ID: 3215429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splanchnic hemodynamics in idiopathic portal hypertension: comparison with chronic persistent hepatitis.
    Ohnishi K; Sato S; Nomura F; Iida S
    Am J Gastroenterol; 1989 Apr; 84(4):403-8. PubMed ID: 2929561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial COX-1 and -2 differentially affect reactivity of MVB in portal hypertensive rats.
    Potenza MA; Botrugno OA; De Salvia MA; Lerro G; Nacci C; Marasciulo FL; Andriantsitohaina R; Mitolo-Chieppa D
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G587-94. PubMed ID: 12181171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
    Shah V
    J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperdynamic circulation in liver cirrhosis: no evidence for peripheral vasodilation detected by ultrasound of the brachial artery.
    Gaenzer H; Sturm W; Neumayr G; Vogel W; Patsch J
    Am J Gastroenterol; 2000 Feb; 95(2):551-2. PubMed ID: 10685770
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular pathophysiology of portal hypertension.
    Fernandez M
    Hepatology; 2015 Apr; 61(4):1406-15. PubMed ID: 25092403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Splanchnic remodeling secondary to experimental prehepatic portal hypertension].
    Corcuera Pindado MT; Nava Hidalgo MP; Angulo Burgos A; Aller Reyero MA; Gómez Aguado F; Casado Fariñas I; Alonso Martín MJ; Pérez AJ
    An Med Interna; 2005 Jul; 22(7):317-22. PubMed ID: 16288575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.